Literature DB >> 18370469

Comparison of Two Oral Morphine Formulations for Chronic Severe Pain of Malignant and Nonmalignant Origin: Kapanol(trade mark) vs MST((R)).

D T Flöter1, D F Koch.   

Abstract

Entities:  

Year:  1998        PMID： 18370469     DOI： 10.2165/00044011-199815010-00011

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  3 in total

1.  [Retard morphine in the long-term therapy of severe tumor pain].

Authors:  M Zenz; M Strumpf; M Tryba; E Röhrs; B Steffmann
Journal:  Dtsch Med Wochenschr       Date:  1989-01-13       Impact factor: 0.628

2.  Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.

Authors:  Geoffrey K Gourlay; David A Cherry; Margaret M Onley; Simon G Tordoff; David A Conn; Gillian M Hood; John L Plummer
Journal:  Pain       Date:  1997-02       Impact factor: 6.961

3.  Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.

Authors:  A Broomhead; R Kerr; W Tester; P O'Meara; C Maccarrone; R Bowles; P Hodsman
Journal:  J Pain Symptom Manage       Date:  1997-08       Impact factor: 3.612
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.